The Ohio-based firm provides design and development across medical, consumer and industrial markets for making smart products.
"The acquisition demonstrates our commitment to innovate for Kaleidoscope clients and make an impact on human lives by combining smart technologies and experiences to revolutionise patient care, treatment, diagnostics and consumer health the world over," the company said in the statement.
Kaleidoscope designs microsurgical instruments, used in invasive surgery, drug delivery devices for ophthalmic therapies and user-centric wearables.
"The acquisition strengthens our digital offerings at the intersection of new software technologies and medical devices, a sector that is expected to witness investments and consumerisation in the post-Covid-19 era," said Infosys President Ravi Kumar.
Global clients of the outsourcing firm will also benefit from the combination of Kaleidoscope's offerings of product innovation and design and its stack of product engineering, validation and commercialisation services at a global scale.
"Device engineering for consumer and medical industries has been a key parameter for our clients. The addition of concept design and human factors engineering, through the acquisition provides us capability and creates an engagement engine," said Infosys' global head of engineering Nitesh Bansal.
Kaleidoscope co-founder and Chief Executive Matt Kornau said becoming a part of Infosys allows it to scale up fast and bring expanded offerings in AI (artificial intelligence), analytics and digital infrastructure to its clients.
"Infosys provides a platform for us to extend our relationship with our business partners to address the productisation of solutions they have been asking us to deliver. We can offer them the scale needed for front-end innovation and back- end implementation and sustainability," Kaleidoscope's other co-founder Bill Taylor said in the statement.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.